@phdthesis{Hammel2024, author = {Hammel, Clara}, title = {Einfluss longitudinaler Ver{\"a}nderungen der linksventrikul{\"a}ren Ejektionsfraktion auf das Langzeit{\"u}berleben bei Herzinsuffizienzpatienten mit leicht reduzierter Ejektionsfraktion oder reduzierter Ejektionsfraktion}, doi = {10.25972/OPUS-36002}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-360025}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2024}, abstract = {Diese retrospektive Studie an der Universit{\"a}tsklinik W{\"u}rzburg diente der Beurteilung der longitudinalen Funktion in Bezug auf die Gesamtmortalit{\"a}t bei Patienten mit HFmrEF und HFrEF. Die Gruppierung erfolgte anhand der jeweiligen Baseline LVEF. Eine weitere Unterteilung erfolgte in eine isch{\"a}mische oder nicht-isch{\"a}mische Genese der HF. Die Subgruppen wurden anhand der Baseline klinischen Charakteristika sowie der echokardiographischen Parameter verglichen. Hier ließ sich ein relativ {\"a}hnliches Patientenklientel mit vergleichbarem Alter, Geschlecht, BMI sowie kardialen Risikofaktoren zeigen. Signifikante Unterschiede ergab der Vergleich des NYHA-Stadiums, der Nierenfunktion sowie des Auftretens von Myokardinfarkten. Die Ver{\"a}nderung der LVEF {\"u}ber die Zeit hat einen zentralen Stellenwert zur Evaluation des Outcomes von Patienten mit HFmrEF und HFrEF. Eine Verbesserung der LVEF fand sich signifikant h{\"a}ufiger bei HFrEF Patienten als bei HFmrEF Patienten, welche {\"u}ber die Zeit signifikant h{\"a}ufiger eine stabile LVEF aufwiesen. Außerdem war nach Auswertung der {\"U}berlebenskurven nach Kaplan-Meier in HFmrEF Patienten eine verbesserte oder unver{\"a}nderte LVEF {\"u}ber die Zeit mit einem besseren {\"U}berleben verbunden, vor allem bei Patienten mit isch{\"a}mischer {\"A}tiologie. In der HFrEF Gruppe konnte gezeigt werden, dass sowohl Patienten mit isch{\"a}mischer als auch mit nicht-isch{\"a}mischer {\"A}tiologie bei Vorliegen einer verbesserten oder unver{\"a}nderten LVEF {\"u}ber die Zeit ein besseres Outcome aufwiesen. Eine erniedrigte MAPSE bedeutete vor allem bei HFmrEF Patienten mit nicht-isch{\"a}mischer {\"A}tiologie ein schlechteres Outcome. Die Ergebnisse dienten unter anderem der weiteren Charakterisierung der HFmrEF und HFrEF Gruppe sowie der Identifikation von Faktoren zur Beurteilung der Ver{\"a}nderung der LVEF {\"u}ber die Zeit und der Prognose des Langzeit{\"u}berlebens beider Gruppen. Ziel f{\"u}r die Zukunft sollte sein, auch f{\"u}r HFmrEF Patienten evidenzbasierte Herzinsuffizienz Therapien zu etablieren.}, subject = {Transthorakale Echokardiographie}, language = {de} } @article{AllertFoersterSvenssonetal.2018, author = {Allert, Stefanie and F{\"o}rster, Toni M. and Svensson, Carl-Magnus and Richardson, Jonathan P. and Pawlik, Tony and Hebecker, Betty and Rudolphi, Sven and Juraschitz, Marc and Schaller, Martin and Blagojevic, Mariana and Morschh{\"a}user, Joachim and Figge, Marc Thilo and Jacobsen, Ilse D. and Naglik, Julian R. and Kasper, Lydia and Mogavero, Selene and Hube, Bernhard}, title = {\(Candida\) \(albicans\)-Induced Epithelial Damage Mediates Translocation through Intestinal Barriers}, series = {mBio}, volume = {9}, journal = {mBio}, number = {3}, doi = {10.1128/mBio.00915-18}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-221084}, pages = {1-20}, year = {2018}, abstract = {Life-threatening systemic infections often occur due to the translocation of pathogens across the gut barrier and into the bloodstream. While the microbial and host mechanisms permitting bacterial gut translocation are well characterized, these mechanisms are still unclear for fungal pathogens such as Candida albicans, a leading cause of nosocomial fungal bloodstream infections. In this study, we dissected the cellular mechanisms of translocation of C. albicans across intestinal epithelia in vitro and identified fungal genes associated with this process. We show that fungal translocation is a dynamic process initiated by invasion and followed by cellular damage and loss of epithelial integrity. A screen of >2,000 C. albicans deletion mutants identified genes required for cellular damage of and translocation across enterocytes. Correlation analysis suggests that hypha formation, barrier damage above a minimum threshold level, and a decreased epithelial integrity are required for efficient fungal translocation. Translocation occurs predominantly via a transcellular route, which is associated with fungus-induced necrotic epithelial damage, but not apoptotic cell death. The cytolytic peptide toxin of C. albicans, candidalysin, was found to be essential for damage of enterocytes and was a key factor in subsequent fungal translocation, suggesting that transcellular translocation of C. albicans through intestinal layers is mediated by candidalysin. However, fungal invasion and low-level translocation can also occur via non-transcellular routes in a candidalysin-independent manner. This is the first study showing translocation of a human-pathogenic fungus across the intestinal barrier being mediated by a peptide toxin. IMPORTANCE Candida albicans, usually a harmless fungus colonizing human mucosae, can cause lethal bloodstream infections when it manages to translocate across the intestinal epithelium. This can result from antibiotic treatment, immune dysfunction, or intestinal damage (e.g., during surgery). However, fungal processes may also contribute. In this study, we investigated the translocation process of C. albicans using in vitro cell culture models. Translocation occurs as a stepwise process starting with invasion, followed by epithelial damage and loss of epithelial integrity. The ability to secrete candidalysin, a peptide toxin deriving from the hyphal protein Ece1, is key: C. albicans hyphae, secreting candidalysin, take advantage of a necrotic weakened epithelium to translocate through the intestinal layer.}, language = {en} } @phdthesis{Abelein2024, author = {Abelein, Christian Karl}, title = {„Ich habe mich so daran gew{\"o}hnt, daß ich beinahe nie dichte ohne zugleich zu singen!" - Der Briefwechsel zwischen August Heinrich Hoffmann von Fallersleben (1798-1874) und Hans Michael Schletterer (1824-1893) als Dokument einer konstruktiven Zusammenarbeit zwischen Dichter und Komponist im 19. Jahrhundert.}, doi = {10.25972/OPUS-36386}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-363862}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2024}, abstract = {Die von Friedhelm Brusniak und Ulrich Konrad betreute und angenommene Dissertation nimmt den Briefwechsel zwischen August Heinrich Hoffmann von Fallersleben und dem j{\"u}ngeren Augsburger Kapellmeister und Komponisten Hans Michael Schletterer in den Jahren 1862 bis 1873 in den Blick und dokumentiert dabei Hoffmanns Einfluss auf den Entstehungsprozess der Vertonungen seiner Lieder, besonders seiner Kinderlieder. Die Arbeit beleuchtet zudem den Erfahrungsschatz, den sich der ‚Dichter-S{\"a}nger' Hoffmann von Fallersleben auch durch die Zusammenarbeit mit anderen Musikern seiner Zeit, vorrangig Ludwig Christian Erk (1807-1883) und Ernst Heinrich Leopold Richter (1805-1876), erworben hatte. Dar{\"u}ber hinaus werden in der Korrespondenz Themen des gesellschaftlichen und politischen Lebens, der privaten und beruflichen Situation beider wie auch Hoffmanns Rolle als v{\"a}terlicher Berater Schletterers ber{\"u}hrt. Die Arbeit darf als neuer substantieller Beitrag der Hoffmann-Forschung und der interdisziplin{\"a}ren Liedforschung angesehen werden, der insbesondere der Kinderliedforschung neue Impulse verleiht.}, subject = {Hoffmann von Fallersleben, August Heinrich}, language = {de} } @article{GhoshHoenscheidDueckersetal.2017, author = {Ghosh, Sujal and H{\"o}nscheid, Andrea and D{\"u}ckers, Gregor and Ginzel, Sebastian and Gohlke, Holger and Gombert, Michael and Kempkes, Bettina and Klapper, Wolfram and Kuhlen, Michaela and Laws, Hans-J{\"u}rgen and Linka, Ren{\´e} Martin and Meisel, Roland and Mielke, Christian and Niehues, Tim and Schindler, Detlev and Schneider, Dominik and Schuster, Friedhelm R. and Speckmann, Carsten and Borkhardt, Arndt}, title = {Human RAD52 - a novel player in DNA repair in cancer and immunodeficiency}, series = {Haematologica}, volume = {102}, journal = {Haematologica}, number = {2}, doi = {10.3324/haematol.2016.155838}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-180862}, pages = {e69-e72}, year = {2017}, abstract = {No abstract available.}, language = {en} } @article{HennrichRomanovHornetal.2018, author = {Hennrich, Marco L. and Romanov, Natalie and Horn, Patrick and Jaeger, Samira and Eckstein, Volker and Steeples, Violetta and Ye, Fei and Ding, Ximing and Poisa-Beiro, Laura and Mang, Ching Lai and Lang, Benjamin and Boultwood, Jacqueline and Luft, Thomas and Zaugg, Judith B. and Pellagatti, Andrea and Bork, Peer and Aloy, Patrick and Gavin, Anne-Claude and Ho, Anthony D.}, title = {Cell-specific proteome analyses of human bone marrow reveal molecular features of age-dependent functional decline}, series = {Nature Communications}, volume = {9}, journal = {Nature Communications}, doi = {10.1038/s41467-018-06353-4}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-319877}, year = {2018}, abstract = {Diminishing potential to replace damaged tissues is a hallmark for ageing of somatic stem cells, but the mechanisms remain elusive. Here, we present proteome-wide atlases of age-associated alterations in human haematopoietic stem and progenitor cells (HPCs) and five other cell populations that constitute the bone marrow niche. For each, the abundance of a large fraction of the ~12,000 proteins identified is assessed in 59 human subjects from different ages. As the HPCs become older, pathways in central carbon metabolism exhibit features reminiscent of the Warburg effect, where glycolytic intermediates are rerouted towards anabolism. Simultaneously, altered abundance of early regulators of HPC differentiation reveals a reduced functionality and a bias towards myeloid differentiation. Ageing causes alterations in the bone marrow niche too, and diminishes the functionality of the pathways involved in HPC homing. The data represent a valuable resource for further analyses, and for validation of knowledge gained from animal models.}, language = {en} } @article{HinesMaricHinesetal.2018, author = {Hines, Rochelle M. and Maric, Hans Michael and Hines, Dustin J. and Modgil, Amit and Panzanelli, Patrizia and Nakamura, Yasuko and Nathanson, Anna J. and Cross, Alan and Deeb, Tarek and Brandon, Nicholas J. and Davies, Paul and Fritschy, Jean-Marc and Schindelin, Hermann and Moss, Stephen J.}, title = {Developmental seizures and mortality result from reducing GABAA receptor α2-subunit interaction with collybistin}, series = {Nature Communications}, volume = {9}, journal = {Nature Communications}, doi = {10.1038/s41467-018-05481-1}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-320719}, year = {2018}, abstract = {Fast inhibitory synaptic transmission is mediated by γ-aminobutyric acid type A receptors (GABAARs) that are enriched at functionally diverse synapses via mechanisms that remain unclear. Using isothermal titration calorimetry and complementary methods we demonstrate an exclusive low micromolar binding of collybistin to the α2-subunit of GABAARs. To explore the biological relevance of collybistin-α2-subunit selectivity, we generate mice with a mutation in the α2-subunit-collybistin binding region (Gabra2-1). The mutation results in loss of a distinct subset of inhibitory synapses and decreased amplitude of inhibitory synaptic currents. Gabra2-1 mice have a striking phenotype characterized by increased susceptibility to seizures and early mortality. Surviving Gabra2-1 mice show anxiety and elevations in electroencephalogram δ power, which are ameliorated by treatment with the α2/α3-selective positive modulator, AZD7325. Taken together, our results demonstrate an α2-subunit selective binding of collybistin, which plays a key role in patterned brain activity, particularly during development.}, language = {en} } @article{HernandezJoseRamirezMinguillonetal.2018, author = {Hern{\´a}ndez, Gonzalo and Jos{\´e} Ram{\´i}rez, Mar{\´i}a and Minguill{\´o}n, Jordi and Quiles, Paco and Ruiz de Garibay, Gorka and Aza-Carmona, Miriam and Bogliolo, Massimo and Pujol, Roser and Prados-Carvajal, Rosario and Fern{\´a}ndez, Juana and Garc{\´i}a, Nadia and L{\´o}pez, Adri{\`a} and Guti{\´e}rrez-Enr{\´i}quez, Sara and Diez, Orland and Ben{\´i}tez, Javier and Salinas, M{\´o}nica and Teul{\´e}, Alex and Brunet, Joan and Radice, Paolo and Peterlongo, Paolo and Schindler, Detlev and Huertas, Pablo and Puente, Xose S. and L{\´a}zaro, Conxi and {\`A}ngel Pujana, Miquel and Surrall{\´e}s, Jordi}, title = {Decapping protein EDC4 regulates DNA repair and phenocopies BRCA1}, series = {Nature Communications}, volume = {9}, journal = {Nature Communications}, doi = {10.1038/s41467-018-03433-3}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-319929}, year = {2018}, abstract = {BRCA1 is a tumor suppressor that regulates DNA repair by homologous recombination. Germline mutations in BRCA1 are associated with increased risk of breast and ovarian cancer and BRCA1 deficient tumors are exquisitely sensitive to poly (ADP-ribose) polymerase (PARP) inhibitors. Therefore, uncovering additional components of this DNA repair pathway is of extreme importance for further understanding cancer development and therapeutic vulnerabilities. Here, we identify EDC4, a known component of processing-bodies and regulator of mRNA decapping, as a member of the BRCA1-BRIP1-TOPBP1 complex. EDC4 plays a key role in homologous recombination by stimulating end resection at double-strand breaks. EDC4 deficiency leads to genome instability and hypersensitivity to DNA interstrand cross-linking drugs and PARP inhibitors. Lack-of-function mutations in EDC4 were detected in BRCA1/2-mutation-negative breast cancer cases, suggesting a role in breast cancer susceptibility. Collectively, this study recognizes EDC4 with a dual role in decapping and DNA repair whose inactivation phenocopies BRCA1 deficiency.}, language = {en} } @phdthesis{Swain2024, author = {Swain, Asim}, title = {Helically Twisted Graphene Nanoribbons: Bottom-up Stereospecific Synthesis and Characterization}, doi = {10.25972/OPUS-36016}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-360164}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2024}, abstract = {Over the past decade, substantial progress has been made in synthesizing atomically precise carbon nanostructures, with a focus on graphene nanoribbons (NRs) through advanced synthetic techniques. Despite these advancements, precise control over the stereochemistry of twisted NRs remains challenging. This thesis introduces a strategic approach to achieve absolute control over the single-handed helical conformation in a cove-edged NR, utilizing enantiopure [n]helicenes as a molecular wrench to intricately dictate the overall conformation of the NR. Enantiopure [7]helicenes were stitched to the terminal K-regions of a conjugated pyrene NR using a stereospecific and site-selective palladium(II)-catalyzed annulative π-extension (APEX) reaction, resulting in a helically twisted NR with an end-to-end twist of 171°, the second-largest twist reported so far in the literature for twistacenes. The helical end-to-end twist increases with each addition of benzene ring to the central acene core, suggesting that the extra strain induced by the terminal [7]helicenes maintains such a high level of twist. The quantum chemical calculations were conducted to investigate the impact of twisting on the conformational population. At room temperature, the central backbone of the nanoribbon adopts the twisted helicity opposite to that of the attached [7]helicene, constituting around 99\% of the molecular population. For instance, (P)-[7]helicenes produce a left-handed helical nanoribbon, while (M)-[7]helicenes produce a right-handed helical nanoribbon. In the presence of helicenes of opposite chirality, the nanoribbon adopts a waggling conformation. The helically twisted nanoribbons are conformationally robust, as variable temperature chiroptical measurements showed no change in CD and CPL spectra. The proposed strategy, involving the late-stage addition of [n]helicene units through the APEX reaction, appears promising for streamlining the synthesis of diverse cove edge NR variants with desired conformations. In addition to single-handed helically twisted nanoribbons, the symmetry-based functional properties of C2 and C1 symmetric pyrene-fused single and double [n]helicene compounds were studied. Owing to its higher structural rigidity, the C1 symmetric heptagonal ring-containing molecules exhibited exceptional configurational stability along with remarkable chiroptical properties compared to their C2 symmetric as well as pristine helicene congeners.}, subject = {Helicene}, language = {en} } @phdthesis{Ramirez2024, author = {Ramirez, Yesid A.}, title = {Structural basis of ubiquitin recognition and rational design of novel covalent inhibitors targeting Cdu1 from \(Chlamydia\) \(Trachomatis\)}, doi = {10.25972/OPUS-19168}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-191683}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2024}, abstract = {The WHO-designated neglected-disease pathogen Chlamydia trachomatis (CT) is a gram-negative bacterium responsible for the most frequently diagnosed sexually transmitted infection worldwide. CT infections can lead to infertility, blindness and reactive arthritis, among others. CT acts as an infectious agent by its ability to evade the immune response of its host, which includes the impairment of the NF-κB mediated inflammatory response and the Mcl1 pro-apoptotic pathway through its deubiquitylating, deneddylating and transacetylating enzyme ChlaDUB1 (Cdu1). Expression of Cdu1 is also connected to host cell Golgi apparatus fragmentation, a key process in CT infections. Cdu1 may this be an attractive drug target for the treatment of CT infections. However, a lead molecule for the development of novel potent inhibitors has been unknown so far. Sequence alignments and phylogenetic searches allocate Cdu1 in the CE clan of cysteine proteases. The adenovirus protease (adenain) also belongs to this clan and shares a high degree of structural similarity with Cdu1. Taking advantage of topological similarities between the active sites of Cdu1 and adenain, a target-hopping approach on a focused set of adenain inhibitors, developed at Novartis, has been pursued. The thereby identified cyano-pyrimidines represent the first active-site directed covalent reversible inhibitors for Cdu1. High-resolution crystal structures of Cdu1 in complex with the covalently bound cyano-pyrimidines as well as with its substrate ubiquitin have been elucidated. The structural data of this thesis, combined with enzymatic assays and covalent docking studies, provide valuable insights into Cdu1s activity, substrate recognition, active site pocket flexibility and potential hotspots for ligand interaction. Structure-informed drug design permitted the optimization of this cyano-pyrimidine based scaffold towards HJR108, the first molecule of its kind specifically designed to disrupt the function of Cdu1. The structures of potentially more potent and selective Cdu1 inhibitors are herein proposed. This thesis provides important insights towards our understanding of the structural basis of ubiquitin recognition by Cdu1, and the basis to design highly specific Cdu1 covalent inhibitors.}, subject = {Ubiquitin}, language = {en} } @phdthesis{Dietrich2024, author = {Dietrich, Oliver}, title = {Integrating single-cell multi-omics to decipher host-pathogen interactions}, doi = {10.25972/OPUS-36013}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-360138}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2024}, abstract = {Interactions between host and pathogen determine the development, progression and outcomes of disease. Medicine benefits from better descriptions of these interactions through increased precision of prevention, diagnosis and treatment of diseases. Single-cell genomics is a disruptive technology revolutionizing science by increasing the resolution with which we study diseases. Cell type specific changes in abundance or gene expression are now routinely investigated in diseases. Meanwhile, detecting cellular phenotypes across diseases can connect scientific fields and fuel discovery. Insights acquired through systematic analysis of high resolution data will soon be translated into clinical practice and improve decision making. Therefore, the continued use of single-cell technologies and their application towards clinical samples will improve molecular interpretation, patient stratification, and the prediction of outcomes. In the past years, I was fortunate to participate in interdisciplinary research groups bridging biology, clinical research and data science. I was able to contribute to diverse projects through computational analysis and biological interpretation of sequencing data. Together, we were able to discover cellular phenotypes that influence disease progression and outcomes as well as the response to treatment. Here, I will present four studies that I have conducted in my PhD. First, we performed a case study of relapse from cell-based immunotherapy in Multiple Myeloma. We identified genomic deletion of the epitope as mechanism of immune escape and implicate heterozygosity or monosomy of the genomic locus at baseline as a potential risk factor. Second, we investigated the pathomechanisms of severe COVID-19 at the earliest stage of the COVID- 19 pandemic in Germany in March 2020. We discovered that profibrotic macrophages and lung fibrosis can be caused by SARS-CoV-2 infection. Third, we used a mouse model of chronic infection with Staphylococcus aureus that causes Osteomyelitis similar to the human disease. We were able to identify dysregulated immunometabolism associated with the generation of myeloid-derived suppressor cells (MDSC). Fourth, we investigated Salmonella infection of the human small intestine in an in vitro model and describe features of pathogen invasion and host response. Overall, I have been able to successfully employ single-cell sequencing to discover important aspects of diseases ranging from development to treatment and outcome. I analyzed samples from the clinics, human donors, mouse models and organoid models to investigate different aspects of diseases and managed to integrate data across sample types, technologies and diseases. Based on successful studies, we increased our efforts to combine data from multiple sources to build comprehensive references for the integration of large collections of clinical samples. Our findings exemplify how single-cell sequencing can improve clinical research and highlights the potential of mechanistic discoveries to drive precision medicine.}, subject = {Einzelzellanalyse}, language = {en} }